CUE
NASDAQ · Biotechnology
Cue Biopharma Inc
$0.32
+0.00 (+1.27%)
CUE News3 articles
Fortescue Retreats as Iron Ore Hovers Near $100, Investors Eye Earnings
Fortescue shares declined 0.96% to A$21.57, giving back some of Monday's gains. Iron ore futures were mixed amid reopened Australian ports and persistent China demand concerns.
Fortescue Leads Mining Rebound as Cyclone Concerns Linger Over Iron Ore
Fortescue shares climbed 2.6% as the ASX 200 recovered 1.9%, driven by a mining sector rebound and rising copper prices. Investors await half-year results amid cyclone disruptions to Pilbara ports.
Cyclone Disrupts Key Iron Ore Port, Fortescue Shares Face Pressure
Fortescue Metals' stock is under scrutiny as Tropical Cyclone Mitchell forces the closure of Port Hedland, threatening iron ore shipments. The miner's half-year results are due later this month.